Rare Disease Pharma: Navigating the DOJ's Sponsored Testing Ruling
The Department of Justice (DOJ) recently made waves in the pharmaceutical industry with a ruling...
Unveiling New Insights in NSCLC with Large-Scale FISH Panel Data
The landscape of Non-Small Cell Lung Cancer (NSCLC) treatment is constantly evolving, with...
Liquid Biopsies: A Game-Changer for Outreach to Healthcare Providers
In the fast-paced world of medicine, staying ahead of the curve is essential for pharmaceutical...
A shift to patient-first at Digital Pharma East
Like many life sciences marketing professionals in the life sciences and pharma industry, I...
Brand Eligible Patient Alerts Supercharge Marketing & Sales Execution
Q: What are alerts? Why are pharma brand teams using brand eligible patient alerts as part of...
The Challenges of Genomics Data for Rare Disease Patients
Niyati Parikh, Vice President, Clinical Solutions
ISPOR 2023: A Focus on Quality
Todd Somsel, Commercial Lead, RWD Marketplace The acceptance and application of real-world evidence...
Reuters Pharma 2023: The Promise and Limitations of RWD
Todd Somsel, Commercial Lead, RWD Marketplace As I reflect on the 2023 edition of the Reuters...
How RWD Marketplaces Help Solve Pharma’s Top 10 Challenges to Gathering Actionable Data
A major step in the process of launching a new drug is compiling and analyzing various real-world...
Plan, Activate, and Optimize Precision HCP Marketing
Without the proper support to know how, when, and where to reach HCPs, it can be challenging to...